XML 46 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenues:      
Revenue $ 306,980 $ 264,734 $ 194,392
Operating expenses:      
Cost of Goods and Services Sold 12,135 12,670 4,577
Amortization of acquired intangible asset 27,650 22,877 15,380
Research and development 257,452 171,984 117,456
Selling, general and administrative 202,541 153,548 121,271
Change in the fair value of deferred and contingent consideration 48,360 19,340 0
Total operating expenses 548,138 380,419 258,684
Loss from operations (241,158) (115,685) (64,292)
Interest expense, net (12,491) (12,554) (12,094)
Other income (expense), net 13,723 129 (1,279)
Loss before income tax expense (239,926) (128,110) (77,665)
Income tax (expense) benefit (11,650) 29 (1,335)
Net loss attributable to common stockholders $ (251,576) $ (128,081) $ (79,000)
Weighted-average shares outstanding:      
Basic and diluted (in shares) 58,863,185 46,576,313 39,183,073
Net loss per share—basic and diluted (in dollars per share) $ (4.27) $ (2.75) $ (2.02)
Net product revenue      
Revenues:      
Revenue $ 291,306 $ 263,005 $ 174,066
Collaboration and grant revenue      
Revenues:      
Revenue $ 15,674 $ 1,729 $ 20,326